Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

书信:行为和压力.

M H Marshall

    JAMA
    |August 19, 1974
    PubMed
    概括

    No abstract available in PubMed .

    相关实验视频

    相关概念视频

    您也可能阅读

    相关文章

    通过共同作者、期刊和引用图与本文相关的文章。

    排序
    Same author

    In vitro cytotoxicity of hepsulfam against human tumor cell lines and primary human tumor colony forming units.

    Stem cells (Dayton, Ohio)·1993
    Same author

    Activity of topotecan, a new topoisomerase I inhibitor, against human tumor colony-forming units in vitro.

    Journal of the National Cancer Institute·1992
    Same author

    Lack of effects of recombinant human interleukin-4 on in vitro colony formation of freshly explanted human tumor cells.

    Investigational new drugs·1992
    Same author

    Effects of recombinant human interleukin-1 alpha on clonogenic growth of primary human tumors in vitro.

    Journal of immunotherapy : official journal of the Society for Biological Therapy·1992
    Same author

    Activity of 2',2'-difluorodeoxycytidine (Gemcitabine) against human tumor colony forming units.

    Anti-cancer drugs·1992
    Same author

    Activity of a recombinant transforming growth factor-alpha-Pseudomonas exotoxin hybrid protein against primary human tumor colony-forming units.

    Investigational new drugs·1992
    Same journal

    Online Prescribing of GLP-1 Receptor Agonists.

    JAMA·2026
    Same journal

    Using AI Disagreement to Expose Gaps in Coverage Rules.

    JAMA·2026
    Same journal

    Randomized Trials in Pregnancy.

    JAMA·2026
    Same journal

    Randomized Trials in Pregnancy-Reply.

    JAMA·2026
    Same journal

    WHO Issues Guidelines for Treating Ebola and Marburg Viruses.

    JAMA·2026
    Same journal

    FDA Approves Additional Naloxone Nasal Spray for Opioid Overdose.

    JAMA·2026
    查看所有相关文章